Title: Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
Journal: Expert review of neurotherapeutics 20111101
Title: Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors.
Journal: European journal of medicinal chemistry 20110501
Title: Quadriparesis and dysarthria due to tetrabenazine therapy in a child with rheumatic chorea.
Journal: Indian journal of pharmacology 20110101
Title: Dantrolene is neuroprotective in Huntington's disease transgenic mouse model.
Journal: Molecular neurodegeneration 20110101
Title: Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
Journal: The American journal of geriatric pharmacotherapy 20100801
Title: Calcium signaling and neurodegeneration.
Journal: Acta naturae 20100401
Title: ELBARA II, an L-band radiometer system for soil moisture research.
Journal: Sensors (Basel, Switzerland) 20100101
Title: Tetrabenazine in the treatment of Huntington's disease.
Journal: Neuropsychiatric disease and treatment 20071001
Title: Podurgiel SJ et al. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine. Behav Brain Res. 2016 Feb 1;298(Pt B):188-91.
Title: Peter D et al. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. J Biol Chem. 1996 Feb 9;271(6):2979-86.
